Euro Med Laboratories Phil : Material Information/Transactions
March 29, 2022 at 08:05 pm EDT
Share
SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C
CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported) Mar 29, 20222. SEC Identification Number 1480223. BIR Tax Identification No. 000-288-655-0004. Exact name of issuer as specified in its charter Euro-Med Laboratories Phil., Inc.5. Province, country or other jurisdiction of incorporation Metro Manila6. Industry Classification Code(SEC Use Only) 7. Address of principal office PPL Building, United Nations Avenue corner San Marcelino St., ManilaPostal Code10078. Issuer's telephone number, including area code 00-63-2-85240091 to 989. Former name or former address, if changed since last report N/A10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares
4,112,140,540
11. Indicate the item numbers reported herein Item 9 : Other Events
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Euro-Med Laboratories Phil., Inc.EURO
PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Issuance of 2021 Audited Financial Statements
Background/Description of the Disclosure
Please be advised that our Board of Directors, at its regular meeting today, March 29, 2022 at 3:00p.m. in which a quorum was present and acted throughout, unanimously approved and authorized the issuance of the Audited Financial Statements of the Company as of and for the year ended December 31, 2021 showing that the Company posted total comprehensive income of Php190.6M.
Other Relevant Information
None
Filed on behalf by:
Name
Janice Ong
Designation
Corporate Secretary
Attachments
Original Link
Original Document
Permalink
Disclaimer
Euro Med Laboratories Phil. Inc. published this content on 30 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2022 00:04:03 UTC.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
